Immunological Adjuvants and Their Modes of Action

Archivum Immunologiae et Therapiae Experimentalis

Volumn 45, Issue 2-3, 1997, Pages 141-147

  Allison, Anthony C ^a  

^a DAWA Inc   (United States)

Author keywords

Adjuvant; Cytokines; Dendritic cells; Follicular dendritic cells; Squalene emulsions

Indexed keywords

ALUMINUM DERIVATIVE; ANTIGEN; CYTOKINE; DRUG DERIVATIVE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN CLASS; IMMUNOLOGICAL ADJUVANT; ISCOM; LIPID A; LIPOSOME; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE; PHOSPHORYL LIPID A; SAPONIN; VACCINE;

ANIMAL; ANTIBODY PRODUCTION; ANTIGEN PRESENTING CELL; BIOSYNTHESIS; CELLULAR IMMUNITY; CLASSIFICATION; COMPLEMENT ACTIVATION; DENDRITIC CELL; DRUG EFFECT; EMULSION; HUMAN; IMMUNOLOGY; MOUSE; MUCOSA; REVIEW; SECRETION; SHEEP;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; ADJUVANTS, IMMUNOLOGIC; ALUMINUM COMPOUNDS; ANIMALS; ANTIBODY FORMATION; ANTIGEN-PRESENTING CELLS; ANTIGENS; COMPLEMENT ACTIVATION; CYTOKINES; DENDRITIC CELLS; EMULSIONS; HUMANS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN ISOTYPES; ISCOMS; LIPID A; LIPOSOMES; MICE; MUCOUS MEMBRANE; SAPONINS; SHEEP; VACCINES;

EID: 2442488936     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. ALLISON A. C. and BYARS N. E. (1986): An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and cell-mediated immunity. J. Immunol. Methods, 2, 369 - 374.
2. ALLISON A. C. and BYARS N. E. (1992): Adjuvants for a new generation of vaccines. Can. J. Infect. Dis., 3, 84 - 96.
3. ALLISON A. C. and DAVIES A. J. S. (1971): Requirement of thymus-dependent lymphocytes for potentiation by adjuvants of antibody formation. Nature, 233, 330 - 332.
4. ALLISON A. C. and GREGORIADIS G. (1974): Liposomes as immunological adjuvants. Nature, 252, 252 - 253.
5. AUDIBERT F. M. and LISE L. D. (1993): Adjuvants: current status, clinical perspectives and future prospects. Immunol. Today, 14, 281 - 284.
6. BYARS N. E., FRASER-SMITH E. B., PECYK R. A., WELCH M., NAKANO K., BURKE R. L., HAYNARD D. R. and ALLISON A. C. (1994): Vaccinating guinea pigs with recombinant glycoprotein D of herpes simplex virus in an efficacious adjuvant formulation elicits protection against vaginal infection. Vaccine, 12, 200 - 209.
7. CLINTON B. A. and WEIGLE W. O. (1972): Cellular events during the induction of experimental thyroiditis in the rabbit. J. Exp. Med., 136, 1605.
8. CUMBERPATCH M. and KIMBER I. (1995): Tumour necrosis factor-α is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization. Immunology, 84, 31 - 35.
9. DEMPSEY P. W., ALLISON M. E. D., AKKARAJU S., GOODNOW C. C. and FEARON D. T. (1996): C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science, 271, 348 - 350.
10. DOHERTY P. C., ALLEN W., EICHELBERGER M. and CARDING S. R. (1992): Roles of ab and gdT-cell subsets in viral immunity. Annu. Rev. Immunol., 10, 123 - 134.
11. ELLOUZ F., ADAM A., CIORBARU R. and LEDERER R. (1974): Minimal structural requirements for adjuvant activity of bacterial peptidoglycans. Biochem. Biophys. Res. Commun., 59, 1317 - 1318.
12. FINKELMAN F. D., HOLMES J., KATONA I. M., URBAN J. F. JR., BECKMANN M. P., PARK L. S., SCHOOLEY K. A., COFFMAN R. L., MOSMANN T. R. and PAUL W. E. (1990): Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol., 8, 303 - 334.
13. GLÜCK R. (1995): Liposomal presentation of antigens for human vaccines. In POWELL M. F. and NEWMAN M. F. (eds.): Vaccine design: The subunit and adjuvant approach. Plenum Press, New York, 325 - 345.
14. GREGORIADIS G. (1990): Immunological adjuvants: A role for liposomes. Immunol. Today, 11, 89 - 97.
15. GREGORIADIS G., WANG Z., BARENHOLZ Y. and FRANCIS M. J. (1993). Liposome-entrapped T-cell peptide provides help for a co-entrapped B-cell peptide to overcome genetic restriction in mice and induce immunological memory. Immunology, 80, 535 - 540.
16. HAMAOKA T., KATZ D. H. and BENACERRAF B. (1973): Haptcn-specific antibody responses in mice. II. Cooperative interactions between adoptively transferred T- and B-lymphocytes in the development of an IgE response. J. Exp. Med., 138, 538 - 556.
17. HEUFLER C, KOCH F. and SCHULER G. (1988): Granulocyte/macrophage colony-stimulating factor and interleukin-1 mediate the maturation of epidermal Langerhans cells into potent immunostimulatory dendritic cells. J. Exp. Med. 167, 700 - 705.
18. JACOB J., KELSOL G., RAJEWSKY K. and WEISS U. (1991): Intraclonal generation of antibody mutants in germinal centres. Nature, 354, 389 - 392.
19. KAMINSKI M. S., KITAMURA K. and MALONEY D. G. (1986): Importance of antibody isotype in monoclonal anti-idiotype therapy of murine B-cell lymphoma. A study of hybridoma class switch variants. J. Immunol., 136, 1123 - 1130.
20. KENNEY J. S., HUGHES B. M. and ALLISON A. C. (1989): Determination of antibody affinity and concentration by solution-phase microradioimmunoassay. In ZOLA H. (ed.): Laboratory methods in immunology. CRC Press, Boca Raton. 209 - 216.
21. KENNEY J. S., HUGHES B. W., MASADA M. P. and ALLISON A. C. (1989): Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies. J. Immunol. Methods, 21, 157 - 166.
22. + T-cells. J. Immunol., 154, 5071 - 5079.
23. MACLENNAN I. C. M. (1994): Germinal centers. Annu. Rev. Immunol., 12, 117 - 139.
24. MEEUSEN E. N. T., PREMIER R. R. and BRANDON M. R. (1996): Tissue-specific migration of lympocytes: a key role for Th1 and Th2 cells? Immunol. Today, 17, 421 - 424.
25. PERSSON G. R., ENGEL D., WHITNEY C., DARUEAU R., WEINBERG A., BRUNSVOLD M. and PAGE R. C. (1994): Immunization against Porphyromonas gingivalis inhibits progression of experimental periodontitis in nonhuman primates. Infect. Immun., 62, 1026.
26. REICHMANN L., CLARK M., WALDMANN H. and WINTER G. (1988): Reshaping human antibodies for therapy. Nature, 332, 323 - 327.
27. RIBI E., ULRICH J. T. and MASIHI K. N. (1993): Immunopotentiating activities of monophosphoryl lipid A. In MAJDE J. A. (ed.): Immunopharmacology of infectious diseases: Vaccine adjuvants and modulation of non-specific resistance. Alan R. Liss, New York, 101 - 1121.
28. RON Y. and SPRENT J. (1987): T-cell priming in vitro: A major role for B-cells in presenting antigen to T-cells in lymph nodes. J. Immunol., 138, 2848 - 2856.
29. ROTHEL J. S., CORNER L. A., SHAW H.-F., WOOD P. R. and LIGHTOWLERS M. W. (1996): Antigen-specific IgA secreting cells induced by peripheral vaccination. Immunol. Cell. Biol., 74, 278.
30. SCHIJNS V. E. C. J., HAAGMANS B., RIJKE E. O., HAUNG S., AGUET M. and HORZUNEK M. C. (1994): IFN-γ receptor-deficient mice generate antiviral Th1-characteristic cytokine profiles but altered antibody responses. J. Immunol., 153, 2029 - 2037.
31. SCHULZ M., ZINKERNAGEL R. M. and HENGARTNER H. (1991): Peptide-induced protection by cytotoxic T-cells. Proc. Natl. Acad. Sci. USA, 88, 991 - 993.
32. SPITZNAGEL J. K. and ALLISON A. C. (1970): Mode of action of adjuvants: effects on antibody responses to macrophage-associated bovine serum albumin. J. Immunol., 104, 128 - 139.
33. STEINMAN R. M. (1991): The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol., 9, 271 - 296.
34. + hemopoietic progenitors. J. Immunol., 157, 1499.
35. SZAKAL A. K., Kosco M. H. and TEW J. G. (1989): Microanatomy of lymphoid tissue during humoral immune responses: Structure-function relationships. Annu. Rev. Immunol., 7, 91 - 109.
36. TEW J. G., DILOSA R. M., BURTON G. F., Kosco M. H., KUPP L. I., MASUDA A. and SZAKAL A. K. (1992): Germinal centres and antibody production in the bone marrow. Immunol. Rev., 126, 99.
37. TOELLNER K.-M., GULBRANSON-JUDGE A., TAYLOR D. R., MAU-YUENSZE D. and MAC LENNAN I. C. M. (1996): Immunoglobulin switch transcript production in vivo related to the site and time of antigen-specific B-cell activation. J. Exp. Med., 183, 2303 - 2312.
38. TOES R. E. M., BLOM R. J. J., OFFRINGA R., KAST W. M. and MELIEF C. J. M. (1996): Enhanced tumor outgrowth after peptide vaccination. J. Immunol., 156, 3911 - 3918.
39. UNANUE E. R., ASKONAS B. A. and ALLISON A. C. (1969): A role of macrophages in the stimulation of immune responses by adjuvants. J. Immunol., 103, 71 - 78.
40. VAN ROOIJEN N. and SANDERS A. (1994): Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol. Methods, 174, 83 - 93.
41. VIJAY H. M., LAVREGNE G., HUANG H. and BERNSTEIN I. L. (1979): Preferential synthesis of IgE reaginic antibodies in rats immunized with alum adsorbed antigens. Int. Arch. Allergy Appl. Immunol., 59, 227 - 232.
42. WALKER B. D., FLEXNER C. and PARADIS T. J. (1988): HIV-1 reverse transcriptase is a target for cytotoxic T-lymphocytes in infected individuals. Science, 240, 64 - 66.
43. WATERS R. V., TERRELL T. G. and JONES G. H. (1986): Uveitis induction in the rabbit by muramyl dipeptides. Infect. Immun., 51, 816 - 825.
44. WHITE R. G. (1976): The adjuvant effect of microbial products on the immune response. Rev. Microbiol. 30, 579 - 600.